XTX Topco’s Hepion Pharmaceuticals HEPA Stock Holding History

XTX Topco’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,361	Closed	-$1.39K	–	2838
2025 Q2	$1.39K	Buy	+17,361	New	+$6.27K	﹤0.01%	2272
2024 Q3	–	Sell	-203	Closed	-$11K	–	2289
2024 Q2	$11K	Buy	+203	New	+$15K	﹤0.01%	1679

XTX Topco's HEPA Position: Q3 2025 in Review

XTX Topco sold out of Hepion Pharmaceuticals (HEPA) in Q3 2025, closing a stake of 17,361 shares — an estimated $1.39K sold.

XTX Topco first reported a position in HEPA in Q2 2024 and held it in 2 quarters. The position peaked at $11K in Q2 2024. 1 fund tracked by Wall St. Rank holds HEPA as of Q3 2025.

XTX Topco reported no remaining Hepion Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
XTX Topco sold 17,361 Hepion Pharmaceuticals shares in Q3 2025, an estimated $1.39K.
XTX Topco first reported a position in Hepion Pharmaceuticals in Q2 2024 and held it in 2 quarters.
XTX Topco's Hepion Pharmaceuticals position peaked at $11K in Q2 2024.
1 fund tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.